Which has grown faster, CHE or CRSP?

Over the past five years, CRSP grew revenue faster — CHE at a 4.12% CAGR versus CRSP at 37.32%.

Does CHE or CRSP pay a bigger dividend?

CHE pays a dividend (0.50% yield), while CRSP has no payments in the available dividend history.

Is CHE or CRSP more profitable?

CHE runs the higher net margin — CHE at 10.60% versus CRSP at -3368.72%.

How have CHE and CRSP total returns compared?

Over the past 5 years, CHE delivered 2.27% and CRSP delivered -13.01% annualized total return. Past performance doesn't predict future results.

Chemed Corporation (CHE) vs CRISPR Therapeutics AG (CRSP)

A side-by-side comparison of Chemed Corporation and CRISPR Therapeutics AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

CHE

Chemed Corporation

$6.63B

$507.50HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

CRSP

CRISPR Therapeutics AG

$5.35B

$55.43HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — CHE vs CRSP

growth of $100 · dividends reinvested · last 10y

CHE +273.9% (+14.1%/yr)CRSP +293.5% (+14.7%/yr)CRSP compounded faster over this window

CHE CRSP

CHE vs CRSP: by the numbers

•CHE is the larger company ($6.63B vs $5.35B market cap).
•CHE is profitable (10.60% net margin) while CRSP runs a net loss (-3368.72%).
•CRSP grew revenue faster over the past five years (37.32% vs 4.12% CAGR).
•CHE pays a dividend (0.50% yield), while CRSP has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CHE	CRSP
P/E ratio	25.48	N/A
Forward P/E	19.91	N/A
P/S ratio	2.56	399.21
P/B ratio	7.99	3.06
EV / EBITDA	16.65	N/A
FCF yield	4.88%	N/A

Profitability

Metric	CHE	CRSP
Gross margin	30.44%	-6537.01%
Operating margin	13.46%	-16191.40%
Net margin	10.60%	-3368.72%
ROE	33.11%	-25.83%
ROIC	19.48%	-21.12%

Dividends

Metric	CHE	CRSP
Dividend yield	0.50%	N/A
Payout ratio	12.55%	N/A

Growth (annualized)

Metric	CHE	CRSP
Revenue CAGR (5Y)	4.12%	37.32%
EPS CAGR (5Y)	-1.65%	N/A
FCF CAGR (5Y)	-5.44%	N/A
Total return CAGR (5Y)	2.27%	-13.01%

Frequently asked

Which has grown faster, CHE or CRSP?: Over the past five years, CRSP grew revenue faster — CHE at a 4.12% CAGR versus CRSP at 37.32%.
Does CHE or CRSP pay a bigger dividend?: CHE pays a dividend (0.50% yield), while CRSP has no payments in the available dividend history.
Is CHE or CRSP more profitable?: CHE runs the higher net margin — CHE at 10.60% versus CRSP at -3368.72%.
How have CHE and CRSP total returns compared?: Over the past 5 years, CHE delivered 2.27% and CRSP delivered -13.01% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CHE analysis Full CRSP analysis Interactive comparison tool

Dig into the metrics

Chemed P/E ratio Chemed dividend yield Chemed ROE CRISPR Therapeutics AG ROE Chemed operating margin CRISPR Therapeutics AG operating margin Chemed revenue growth CRISPR Therapeutics AG revenue growth Chemed free cash flow CRISPR Therapeutics AG free cash flow

Chemed & CRISPR Therapeutics AG appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.